Back
Relmada Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
60
RLMD
Relmada Therapeutics, Inc.
Last Price:
$4.60
Seasonality Move:
6.09%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RLMD is experiencing slight buying pressure.
Relmada Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.37 | Buy |
| 20-day SMA: | 4.27 | Buy |
| 50-day SMA: | 3.49 | Buy |
| 200-day SMA: | 1.47 | Buy |
| 8-day EMA: | 3.45 | Buy |
| 20-day EMA: | 1.98 | Buy |
| 50-day EMA: | 0.93 | Buy |
| 200-day EMA: | 0.25 | Buy |
Relmada Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.17 | Buy |
| Relative Strength Index (14 RSI): | 62.39 | Buy |
| Chaikin Money Flow: | 95828 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.1 - 4.44) | Buy |
| Bollinger Bands (100): | (1.1 - 3.76) | Buy |
Relmada Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Relmada Therapeutics, Inc. Stock
Is Relmada Therapeutics, Inc. Stock a Buy?
-
Relmada Therapeutics, Inc. share price is 4.60 while RLMD 8-day simple moving average is 4.37, which is a Buy signal.
-
The stock price of RLMD is 4.60 while Relmada Therapeutics, Inc. 20-day SMA is 4.27, which makes it a Buy.
-
Relmada Therapeutics, Inc. 50-day simple moving average is 3.49 while RLMD share price is 4.60, making it a Buy technically.
-
RLMD stock price is 4.60 and Relmada Therapeutics, Inc. 200-day simple moving average is 1.47, creating a Buy signal.
RLMD Technical Analysis vs Fundamental Analysis
Buy
60
Relmada Therapeutics, Inc. (RLMD)
is a Buy
Is Relmada Therapeutics, Inc. a Buy or a Sell?
-
Relmada Therapeutics, Inc. stock is rated a BuyThe current Relmada Therapeutics, Inc. [RLMD] share price is $4.60. The Score for RLMD is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Relmada Therapeutics, Inc. Stock Info
Market Cap:
337.3M
Price in USD:
4.60
Share Volume:
335.4K
Relmada Therapeutics, Inc. 52-Week Range
52-Week High:
5.12
52-Week Low:
0.24
Buy
60
Relmada Therapeutics, Inc. (RLMD)
is a Buy
Relmada Therapeutics, Inc. Share Price Forecast
-
What is the Relmada Therapeutics, Inc. stock price today?The Relmada Therapeutics, Inc. stock price is 4.60 USD today.
-
Will RLMD stock go up or go down?Relmada Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Relmada Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Relmada Therapeutics, Inc. is not overvalued.
Is Relmada Therapeutics, Inc. Stock a Buy?
-
Relmada Therapeutics, Inc. share price is 4.60 while RLMD 8-day exponential moving average is 3.45, which is a Buy signal.
-
The stock price of RLMD is 4.60 while Relmada Therapeutics, Inc. 20-day EMA is 1.98, which makes it a Buy.
-
Relmada Therapeutics, Inc. 50-day exponential moving average is 0.93 while RLMD share price is 4.60, making it a Buy technically.
-
RLMD stock price is 4.60 and Relmada Therapeutics, Inc. 200-day simple moving average is 0.25, creating a Buy signal.
Fundamental Analysis of Relmada Therapeutics, Inc.
Is Relmada Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.89 per share, and an increase next year of $0.47 per share.
Technical Analysis of Relmada Therapeutics, Inc.
Should I short Relmada Therapeutics, Inc. stock?
-
RLMD Moving Average Covergence Divergence (MACD) indicator is 1.17, suggesting Relmada Therapeutics, Inc. is a Buy
-
Relmada Therapeutics, Inc. Relative Strength Index (RSI) is 62.39, which suggest Relmada Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Relmada Therapeutics, Inc. is (4.1 - 4.44), which suggest Relmada Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Relmada Therapeutics, Inc. is (1.1 - 3.76), which suggest Relmada Therapeutics, Inc. is a Buy
* Relmada Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.